Skip to main content
An official website of the United States government

MRS with Deuterated Glucose for Assessing Brain Metabolism in Patients with Glioma

Trial Status: active

This study assesses the usefulness of new metabolic imaging with deuterated glucose and magnetic resonance spectroscopy (MRS) in patients with glioma. Deuterium (also known as heavy hydrogen)-labeled glucose is a form of non-radioactive sugar. MRS detects the chemical composition of the brain. Information gained in this study may help doctors learn more metabolic information about brain tumors. It is hoped that this information will help researchers learn more about practical ways of evaluating treatment, which may benefit future patients with brain tumors.